Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.580 +0.030 (+1.94%)

Streaming Delayed Price Updated: 3:12 PM EDT, Mar 27, 2026 Add to My Watchlist

Price and Volume

Volume	968,197
Open	1.540
Bid (Size)	1.570 (6,600)
Ask (Size)	1.580 (5,700)
Prev. Close	1.550
Today's Range	1.500 - 1.580
52wk Range	1.300 - 2.979
Shares Outstanding	210,356,896
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

March 25, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	-6.5%	-6.5%
1 Month	-16.4%	-16.4%
3 Month	-31.0%	-31.0%
6 Month	-35.0%	-35.0%
1 Year	-9.7%	-9.7%

More News

INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

March 24, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 23, 2026

From Schall Law

Via GlobeNewswire

Robbins LLP Reminds Inovio Pharmaceuticals, Inc. Stockholders of the Pending Class Action Against INO and Urges Harmed Stockholders to Seek More Information

March 20, 2026

From Robbins LLP

Via Business Wire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 19, 2026

From Schall Law

Via GlobeNewswire

INO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

March 18, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

Inovio (INO) Q4 2025 Earnings Call Transcript ↗

March 17, 2026

Via The Motley Fool

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 16, 2026

From Schall Law

Via GlobeNewswire

Inovio Stock Up On Earnings, Pipeline Progress ↗

March 13, 2026

Via Benzinga

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 13, 2026

From Schall Law

Via GlobeNewswire

INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

March 13, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

March 10, 2026

From Pomerantz LLP

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 10, 2026

From Schall Law

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PomDoctor and Inovio and Encourages Investors to Contact the Firm

March 09, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

March 06, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 06, 2026

From Schall Law

Via GlobeNewswire

UPCOMING DEADLINE: Inovio Pharmaceuticals (INO) Securities Fraud Class Action – April 7, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP

March 04, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

March 03, 2026

From Pomerantz LLP

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 03, 2026

From Schall Law

Via GlobeNewswire

INO CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

February 25, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

February 25, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

February 24, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

February 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Frequently Asked Questions

Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?

Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market

What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?

The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.580

When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 03/27/26 03:12 PM ET

What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 332.36M

How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?

Inovio Pharmaceuticals, Inc. - Common Stock has 332M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.